philadelphia lawyers
Bisphosphonate Lawsuit & News Blog
Bisphosphonate Lawsuits
  and Class Actions | Bisphosphonates Blog Home | Bisphosphonate Archives | Bisphosphonate Articles | Bisphosphonate Category Index |
Do I have a Actonel Lawsuit? | Do I have a Zometa Lawsuit? | Do I have a Boniva Lawsuit? | Do I have a Aredia Lawsuit? | Do I have a Fosamax Case?
Bisphosphonate Lawsuits
  and Class Actions : Bisphosphonates Blog Home : January 2007 : 2007-01-01 to 2007-01-07

Drug Tainted Journalism in the Journal of American Medicine (JAMA)
January 5, 2007 15:05

In the December 27, 2006 issue of JAMA, the article "Effects of Continuing or Stopping Alendronate after 5 Years of Treatment" was funded by Merck who manufactures alendronate, a bisphosphonate, under the patent name Fosamax.Not only was the study supported... (Read Article)

2006-12-11 to 2006-12-17 «  » 2007-01-08 to 2007-01-14

© 2008 copyright Anapol Schwartz.
Ask our Lawyers | About Fosamax ONJ | Blog | Site Map | Home | AddThis Social Bookmark Button

Disclaimer: Pennsylvania Fosamax Attorney Disclaimer: Fosamax Lawyers, Lawsuits, Class Actions, or other legal information set forth in this site should not be construed to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Please contact a Pennsylvania Osteonecrosis Lawyer at our law firm for information regarding your particular case. This website is not intended to solicit clients outside the States of New Jersey and Pennsylvania.